Tap into the latest knowledge and approaches to vascular medicine with the comprehensive, clinically oriented coverage of this new addition to the Braunwald’s Heart Disease family. You’ll find today’s best methods for identifying and treating arterial diseases of the limbs * renal, mesenteric and cerebral circulation problems * aortic aneurysms * vasospastic diseases * vasculitides * venous thromboembolisms * lymphedema * and much more. * Integrates a contemporary understanding of vascular biology with a thorough review of clinical vascular disease. * Covers the fundamental biology of blood vessels and the pathobiologic foundation of vascular disease. * Provides an in-depth, state-of-the-art review of all vascular diseases with emphasis on pathophysiology, diagnosis, and management. * Discusses all of the latest advances in vascular medicine and facilitates the accurate diagnosis, evaluation, and treatment of vascular disease.
Pulmonary arterial hypertension (PAH) is a rare condition with an estimated 146,000 sufferers across the United States, Europe and Japan, yet is estimated that up to 75 per cent of these patients are not recognized and treated. However, in recent years there has been significant investment in developing new therapies, and treatment for this previously neglected disease is set to enter a new era.This new work draws on the recent published literature and reports on clinical trials, to review the latest developments in our understanding of the disease, new advances in therapy and current opinion on best practice approaches to management. Internationally-recognised authorities on PAH provide expert analysis of these advances and critical commentary on the data presented and the implications of these findings for future clinical practice. This book covers primary research and future developments in addition to current practice and the latest trials; offers evidence-based solutions by experts; and, presents a comprehensive review of current treatment options in this complex field.
Sudden cardiac death (SCD) is usually the result of a cardiac arrhythmia, mainly ventricular fibrillation, and is one of the leading causes of death in the occidental world, accounting for 300,000 to 500,000 deaths each year only in the United States. The scientific debate is still open about the risk factors leading to SCD; that knowledge represents a crucial step in order to solve and prevent this too common problem. The correct identification of the risk factors for sudden death can favour the correct strategies to minimise this risk. Those are mainly the type and severity of underlying heart disease as well as specific electrophysiologic findings diagnosed at EKG or through other specific tests. The optimal treatment of some of those diseases such as the most known ischemic heart disease can minimize the risk of SCD during follow-up. However many people continue to die from ventricular fibrillation, because not always predictable and often due to direct the delay inherent in getting an ambulance to the cardiac arrest victim within those critical first 5 minutes. In the mid-1990s, a new generation of computerized defibrillators was introduced. These devices, called Automated External Defibrillators (AED), are capable of interpreting a person's heart rhythm and delivering a defibrillation shock with only minimal input from the operator. Today, many states have true public access defibrillation programs and in USA recently FDA allowed their selling in the food and drug stores. This book provides review in-depth of all important aspects of SCD and contemporary guidelines concerning risk stratification and therapeutic approaches. The major treatments for patients at very high risk for sudden cardiac death include implantable cardiac defibrillators, pacemakers, and anti-arrhythmic medications. The main purpose of this book is to enphasize the importance of adequate clinical approach to patients at risk and to describe the rationale for clinical management of these patients. In addition the way to develop early defibrillation programs in the community will be extensively considered.
Interpreting Difficult ECGs: A Rapid Reference provides nurses and other health care professionals with systematic methods for interpreting difficult waveforms--from arrhythmias to ECG changes in acute coronary syndromes, bundle branch block, hypertrophy, and abnormalities caused by electrolyte disturbances and drugs. Chapters cover ECG fundamentals, interpreting rhythm strips, interpreting 12-lead ECGs, and understanding the effects of drugs, pacemakers, and other treatments on ECGs. The book contains more than 200 illustrations, including graphic waveforms, exact lead placement, and charts of key concepts such as selecting the best monitoring lead. A section of practice strips is included. Helpful quick-reference appendices cover major arrhythmias and antiarrhythmic drugs.
Tightly organized into a super-condensed outline bulleted format, this handy, pocket-sized manual details precise, up-to-date information for diagnosis and treatment of Valvular Heart Disease. Throughout the book, tables and figures summarize important clinical data and current professional society recommendations, while salient references direct readers to additional information. Current, quick, and concise, for instant access on the ward or in the clinic!
Cardiac Catheterization and Coronary Angiography is the first handbook-sized practical training guide for cardiology medical and technical personnel who want easily accessible, detailed information on how to perform a comprehensive left and/or right heart catheterization procedure, choose the correct catheter for coronary and graft angiography, perform a diagnostic coronary angiogram and interpret and understand their findings. Based on international cardiology and interventional society guidelines, it aims to demystify the investigations while remaining authoritative and concise.
